Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aso International's revenue for the
three
months ended in Dec. 2025 was 円1,021 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2025 was 円4,037 Mil.
Aso International's Revenue per Share for the
three
months ended in Dec. 2025 was 円102.28.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was 円404.62.
During the past 5 years, Aso International's highest 3-Year average Revenue per Share Growth Rate was 4.30% per year. The lowest was -0.70% per year. And the median was 1.80% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Aso International Revenue Related Terms
Aso International Revenue Historical Data
* Premium members only.
The historical data trend for Aso International's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Aso International's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aso International Revenue vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aso International's Revenue distribution charts can be found below:
* The bar in red indicates where Aso International's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円4,037 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aso International (TSE:9340) has a Revenue of 円4,037 Mil as of Dec. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on Aso International and its competitors.
Is Aso International's Revenue too high?
Aso International's current Revenue is 円4,037 Mil. Overall, Aso International has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aso International's Revenue compare to ISRG and BDX?
Aso International's Revenue of 円4,037 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Devices & Instruments company?
A good Revenue depends on the Medical Devices & Instruments industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Aso International and its competitors. Aso International's current Revenue is 円4,037 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aso International stock overvalued right now?
Based on GuruFocus' analysis, Aso International (TSE:9340) is currently considered Modestly Overvalued. The stock's GF Value™ is 円613.94, compared to a current price of 円710.00 — trading 15.6% above its estimated fair value. The current Revenue is 円4,037 Mil. Aso International's overall GF Score™ is 62/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Aso International (TSE:9340), the current Revenue is 円4,037 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aso International (TSE:9340) Overvalued in 2026?
Based on GuruFocus' analysis, Aso International stock appears to be overvalued.
The current stock price of 円710.00 is trading 15.6% above its estimated GF Value™ of 円613.94.
GuruFocus considers Aso International to be Modestly Overvalued.
Key valuation signals for TSE:9340:
Revenue: 円4,037 Mil
GF Value™: 円613.94 vs. price of 円710.00 (15.6% above fair value)
No single metric tells the full story. See the TSE:9340 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aso International Inc is engaged in the manufacturing and sale of orthodontic appliances. The company mainly manufactures and supplies custom-made orthodontic dental prostheses to dental medical institutions. Its product portfolio comprises Aso Liner, Specter 4D Print Retainer, 3D printers for dental prostheses, Harmony, a lingual orthodontic system, and various types of retainers, among others. The group operates in a single segment, the orthodontic business.
62GF Score
Get the complete analysis for TSE:9340
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9340 has been successfully added to your 
